Endo International plc (ENDPQ)

Drugmaker Endo receives US court approval for bankruptcy restructuring

As part of the bankruptcy plan, over 95% of the company's ownership will be handed over to its lender group, which includes investment firms Oaktree Capital Management, Silver Point Capital and Bain Capital. Endo had last month agreed to pay up to $465 million over a decade to resolve over $7 billion in claims for purported tax debts, a criminal investigation into the company's opioid marketing and the federal government's possible overpayment for its medications. Endo filed for bankruptcy in August 2022 to address its $8 billion debt and thousands of lawsuits over its alleged role in the U.S. opioid epidemic.